Zydus launches anti-cancer generic drug olaparib in India

The drug will target specific genetic mutations prevalent in certain types of cancers, paving the way for a more tailored and effective treatment approach, the company said in a stock exchange filing. The drug will target specific genetic mutations prevalent in certain types of cancers, paving the way for a more tailored and effective treatment approach.
Source: The Economic Times Healthcare and Biotech News - Category: Pharmaceuticals Source Type: news